-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Ulcerative colitis (UC) patients are prone to develop pouch inflammation after ileo-anal anastomosis (IPAA), and pouchitis is the most common complication after IPAA for the treatment of UC
Ulcerative colitis (UC) patients are prone to develop pouch inflammation after ileo-anal anastomosis (IPAA), and pouchitis is the most common complication after IPAA for the treatment of UC
The results of the study showed that 41 patients received vancomycin for chronic pouch inflammation
Figure: The therapeutic effect of different antibiotics on chronic pouchitis
Figure: The therapeutic effect of different antibiotics on chronic pouchitisThis study confirms that in a retrospective analysis of the efficacy of vancomycin in the treatment of chronic pouch-related disease, the researchers found that approximately half of the patients showed a clinical response at 4 weeks
This study confirms that in a retrospective analysis of the efficacy of vancomycin in the treatment of chronic pouch-related disease, the researchers found that approximately half of the patients showed a clinical response at 4 weeks
Original source:
Gabriel Lupu.
Gabriel Lupu.
Et al.
Vancomycin Is Effective in the Treatment of Chronic Inflammatory Conditions of the Pouch.
Inflammatory Bowel Diseases.
2022.
Vancomycin Is Effective in the Treatment of Chronic Inflammatory Conditions of the Pouch.
Leave a Comment